Latest Breaking News On - Suzanne ildstad - Page 4 : comparemela.com

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 21,753 shares of the company’s stock in a transaction dated Wednesday, April 19th. The stock was sold at an average price of $2.16, for a total value of $46,986.48. Following the completion of the transaction, the director now directly owns 2,883,389 shares of the […]

United statesSuzanne ildstadSg americas securitiesSecurities exchange commissionTalaris therapeutics incMorgan stanleyProspera financial services incSquarepoint opsChicago partners investment groupCommonwealth equity servicesTalaris therapeuticsGet ratingDirector suzanne ildstadExchange commissionPartners investment groupEquity services